AMANDA LIPSCOMB: Open Payments
NPI 1316207186 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 83 payments from 17 companies in 2025. Trend: 2023 $1,119 · 2024 $2,008 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $602 |
| Janssen Biotech, Inc. | 11 | $263 |
| Madrigal Pharmaceuticals | 6 | $244 |
| Gilead Sciences, Inc. | 8 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $176 |
| Ardelyx, Inc. | 4 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
| Intercept Pharmaceuticals, Inc. | 2 | $53 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, ENTYVIO, CREON, IBSRELA, SKYRIZI, LINZESS.
Industry payments across FL — which companies pay providers there.
